rutvikmavani3813@gmail.com 
Bitcoin nearly touched the $72,000 mark on Wednesday, marking the second straight day of its massive retreat this week. The world’s oldest cryptocurrency sank as low as $72,096.20, plunging more than 5% on the day. It was last trading at $72,958.38, down about 4% on the day. Bitcoin is currently more than 40% off its record … Read more
Silver fell sharply, wiping out a two-day recovery, as the white metal struggled to find a floor following a historic market rout. Gold also declined. Spot silver plunged as much as 17% on Thursday, having flickered briefly above $90 an ounce in early Asian trading. After a record-breaking rally that appeared to run too far, … Read more
Sony on Thursday reported a rise in operating profit that beat expectations, supported by favorable foreign exchange rates despite surging memory chip costs. Here are Sony’s December quarter results compared with LSEG SmartEstimates, which are weighted toward forecasts from analysts who are more consistently accurate: Operating profit jumped 22% from a year earlier, rebounding from a … Read more
Market Volatility and Price Decline Bitcoin’s attempt at a recovery following a red weekend proved short-lived as a fresh wave of selling pushed the cryptocurrency below the $73,000 mark. According to Bitstamp data, the digital asset plummeted to an intraday low of $72,863—a nearly 7% decline from its morning opening of just under $79,000. Consistent with the trends of … Read more
Gold and silver prices extended their rally on Wednesday, with analysts saying further gains will likely be determined by the direction of foreign exchange and interest rate expectations. Spot gold was up 2.4% at $5,054.6 per ounce as of 5:37 a.m. ET, while gold futures gained about 3.4%, to $5,1 . Meanwhile spot silver was up 5.8% $90 per ounce. Silver … Read more
Eli Lilly & Co Eli Lilly produces brand-name prescription drugs to treat a wide range of medical conditions, including diabetes, cancer and neurological disorders. Analyst Sel Hardy says Medicare beneficiaries will be getting a capped $50 per month copay for Lilly’s GLP-1 weight-loss drug Zepbound starting in April, which he says will be a significant tailwind for … Read more
Netflix co-CEO Ted Sarandos on Tuesday faced skeptical lawmakers during a Senate hearing on his company’s pending $83 billion deal to acquire Warner Bros. Discovery’s streaming and studio assets. While many senators grilled Sarandos over antitrust issues, labor concerns and consumer prices, several conservative members focused instead on unsubstantiated accusations that Netflix promotes “woke” content … Read more
For U.S. initial public offerings, 2026 is starting out as a slow burn, with 24 IPOs filed so far, down 11.1% from the same period in 2025, according to Renaissance Capital. Additionally, just nine IPOs have been priced in the U.S. market in 2026, down 47.1% from last year. Proceeds raised so far total $2.6 … Read more
Legendary investor Ray Dalio warned on Tuesday that the world is “on the brink” of a capital war, amid simmering geopolitical tensions and volatile capital markets. “We are on the brink,” Dalio said. “That means not in, but it means we are quite close to [capital war], and it would be very easy to go … Read more
Feb 3 (Reuters) – A new probe of Swiss bank Credit Suisse discovered 890 previously undisclosed accounts with potential Nazi links, a U.S. senator said on Tuesday, amid efforts to shine a light on what he said was the bank’s hidden role in World War Two crimes. Holders of the wartime accounts included the German … Read more